Robert A. Figlin, MD,
Editor-in- Chief of the Kidney Cancer Journal.
These recommended abstracts from ESMO 2022 Annual meeting have been selected by Robert A. Figlin, MD, Editor-in- Chief of the Kidney Cancer Journal. The chosen abstracts provided here highlight some of the most important trends in ongoing trials and reflect the foremost research and strategies from latest clinical trials that impact the current standard of care in renal cancer.
Abstract Titles
ABSTRACT LBA8:
ABSTRACT 14480:
ABSTRACT 14470:
ABSTRACT 1464P:
ABSTRACT 1466P
ABSTRACT 1450MO
ABSTRACT 1677P
ABSTRACT 1451MO
ABSTRACT 1461P
ABSTRACT 1453P
